Physician profile
Christopher A Conn
NPI 1164440830
$15,951.37
in general payments reported to CMS, 2019-2025
18 companies · $4,868 in 2025
The $4,868 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,222 · 2020: $114 · 2021: $211 · 2022: $89.12 · 2023: $6,031 · 2024: $2,416 · 2025: $4,868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $9,600 · Debt Forgiveness: $3,613 · Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $9,600.00 |
| Debt Forgiveness | $3,612.50 |
| Food and Beverage | $102.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $13,212.50 | 2023-2025 | Venacure 1470 Pro, Venacure Evlt |
| Steris Corporation | $2,082.85 | 2019 | |
| Abbvie INC. | $174.52 | 2021-2025 | Dalvance |
| Intuitive Surgical, INC. | $72.62 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $61.21 | 2020-2021 | |
| Kerecis Limited | $60.01 | 2021 | |
| Medtronic, INC. | $39.18 | 2021 | |
| Depuy Synthes Sales INC. | $38.75 | 2021 | |
| Integra Lifesciences Corporation | $31.67 | 2020 | |
| Organogenesis INC. | $27.78 | 2019 | |
| Smith+Nephew, INC. | $27.52 | 2019 | |
| Lsi Solutions INC | $22.83 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.36 | 2022 | |
| Acell, INC. | $20.06 | 2019 | |
| Tela Bio, INC. | $15.54 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $14.71 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.09 | 2020 | |
| Thd America, INC. | $13.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Conn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.